Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > 1St quarter BTD

<< Previous

Bullboard Posts

Next >>

Comment by DeathXray33on Nov 30, 2023 5:15pm

171 Views

Post# 35762219

RE:RE:RE:RE:RE:RE:RE:RE:1St quarter BTD

enriquesuave wrote: Data is definitely looking better and better! Optimized patients show 38% CR at 450 days plus 5% IR. This kills bot Keytruda at 19% CR and Adstiladrin at 23.5%. Also looks like we will gain an extra 5-10% higher in CR rates as we move in time. Perhaps even more if 3rd treatment is administered to some and found beneficial.

I'm buying more tomorrow...

<< Previous

Bullboard Posts

Next >>

5 steps to mastering risk management in the stock market